Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

StUngarjr Jun. 18 at 9:53 PM

$PFE This is a distinct possibility now, though I hope not. New CFO comes in without being bound by past promises. Throws in a kitchen sink quarter, then sets bar lower to make his job easier, which allows him to slash the dividend by more than half justifying it by telling street it’s for future growth. Stock becomes a teenager and all the so called conservative value people tell you what a great buy it is now and to average down even more. Good Luck Value trappers

0 · Reply

mikesterz7 Jun. 18 at 9:26 PM

$PFE Pfizer said Executive Vice President and Chief Financial Officer Dave Denton notified the company on June 16 that he will step down effective August 15.

0 · Reply

Stellar2X Jun. 18 at 9:25 PM

$PFE $WKSP $KLAC $STRC lude

0 · Reply

Micheal_Pothead Jun. 18 at 8:54 PM

$PFE we were 1 letter off being up 20% today

3 · Reply

Micheal_Pothead Jun. 18 at 8:15 PM

$PFE insane AH volume

2 · Reply

superpiterpan Jun. 18 at 8:08 PM

$PFE 30mln shares at closing? Who dumped that much?

1 · Reply

Micheal_Pothead Jun. 18 at 8:04 PM

$PFE worthless

0 · Reply

Zurek4 Jun. 18 at 7:55 PM

$PFE 8 million buy imbalance

0 · Reply

notreload_ai Jun. 18 at 7:47 PM

$PFE announced that CFO Dave Denton will leave the company on August 15, 2026, for a new role in consumer goods. Cecile Guegan named Interim CFO as the company reaffirms its 2026 guidance. https://notreload.xyz/xy/pfizer-announces-departure-of-cfo-dave-denton-names-interim-successor/

0 · Reply

PFElinepfrenzy1990 Jun. 18 at 7:44 PM

$PFE

0 · Reply

Pfizer (PFE) Shares Sink After Surprise CFO Exit

2026-06-18T17:30:31.000Z - 5 hours ago

Pfizer reaffirms all components of FY26 guidance

2026-06-18T10:52:33.000Z - 11 hours ago

Pfizer CFO Dave Denton to step down, Cecile Guegan named interim CFO

Jun 18, 2026, 6:52 AM EDT - 11 hours ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 12 hours ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 8 days ago

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-09T21:05:52.000Z - 9 days ago

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

2026-06-09T21:05:12.000Z - 9 days ago

Pfizer upgraded to Sector Perform at RBC Capital amid more balanced risk-reward

Jun 9, 2026, 2:07 PM EDT - 9 days ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 9 days ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 9 days ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 10 days ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-08T10:51:57.000Z - 10 days ago

Pfizer says FDA approves expanded indication for Hympavzi

Jun 8, 2026, 6:49 AM EDT - 10 days ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 10 days ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

2026-06-07T22:00:49.000Z - 11 days ago

Pfizer presents results from Phase 2b studies of berobenatide

Jun 6, 2026, 11:00 AM EDT - 12 days ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 12 days ago

Pfizer Slides: Study update

Jun 6, 2026, 9:06 AM EDT - 12 days ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 12 days ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 14 days ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 14 days ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 15 days ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 17 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

2026-05-31T13:45:07.000Z - 18 days ago

Pfizer announces results from Cohort 3 on Bratovi with cetuximab, Folfiri

2026-05-31T13:25:52.000Z - 18 days ago

Pfizer announces results from Phase 3 Talapro-3 study of Talzenna, Xtandi

May 31, 2026, 8:00 AM EDT - 18 days ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 9:22 AM EDT - 19 days ago

Mailbag: A Follow-Up on Pfizer & Other Questions

AGNC LAND NLY PFFA

May 30, 2026, 8:00 AM EDT - 19 days ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

2026-05-29T13:17:15.000Z - 20 days ago

Pfizer announces seven-year follow-up results from Phase 3 CROWN trial

May 29, 2026, 8:00 AM EDT - 20 days ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 20 days ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 20 days ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

2026-05-28T23:05:16.000Z - 20 days ago

Pfizer enters into global strategic collaboration with Innovent Biologics

May 28, 2026, 7:00 PM EDT - 20 days ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 20 days ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 22 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 4 weeks ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 4 weeks ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 4 weeks ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 18, 2026, 8:00 AM EDT - 4 weeks ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 5 weeks ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

May 13, 2026, 6:45 AM EDT - 5 weeks ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

May 12, 2026, 7:00 AM EDT - 5 weeks ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

May 5, 2026, 4:09 PM EDT - 6 weeks ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 6 weeks ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 6 weeks ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 6 weeks ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 6 weeks ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 6 weeks ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 6 weeks ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 6 weeks ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 6 weeks ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 1, 2026, 12:37 PM EDT - 6 weeks ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Apr 29, 2026, 7:42 AM EDT - 7 weeks ago

Pfizer's blood cancer drug meets main goal in late-stage trial

$Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma$

Apr 29, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 28, 2026, 10:41 AM EDT - 7 weeks ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:17 AM EDT - 7 weeks ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 24, 2026, 8:36 AM EDT - 7 weeks ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Apr 23, 2026, 9:00 AM EDT - 2 months ago

Pfizer Transcript: AGM 2026

Apr 22, 2026, 4:45 PM EDT - 2 months ago

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 5:18 AM EDT - 2 months ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 21, 2026, 11:51 AM EDT - 2 months ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 20, 2026, 3:05 PM EDT - 2 months ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

StUngarjr Jun. 18 at 9:53 PM

0 · Reply

mikesterz7 Jun. 18 at 9:26 PM

$PFE Pfizer said Executive Vice President and Chief Financial Officer Dave Denton notified the company on June 16 that he will step down effective August 15.

0 · Reply

Stellar2X Jun. 18 at 9:25 PM

$PFE $WKSP $KLAC $STRC lude

0 · Reply

Micheal_Pothead Jun. 18 at 8:54 PM

$PFE we were 1 letter off being up 20% today

3 · Reply

Micheal_Pothead Jun. 18 at 8:15 PM

$PFE insane AH volume

2 · Reply

superpiterpan Jun. 18 at 8:08 PM

$PFE 30mln shares at closing? Who dumped that much?

1 · Reply

Micheal_Pothead Jun. 18 at 8:04 PM

$PFE worthless

0 · Reply

Zurek4 Jun. 18 at 7:55 PM

$PFE 8 million buy imbalance

0 · Reply

notreload_ai Jun. 18 at 7:47 PM

0 · Reply

PFElinepfrenzy1990 Jun. 18 at 7:44 PM

$PFE

0 · Reply

PFElinepfrenzy1990 Jun. 18 at 7:42 PM

$PFE

0 · Reply

Micheal_Pothead Jun. 18 at 7:37 PM

$PFE no of course not, they still short every pop

0 · Reply

superpiterpan Jun. 18 at 7:36 PM

$PFE started new pos, 10,000 shares. Target 20,000

1 · Reply

Micheal_Pothead Jun. 18 at 7:33 PM

$PFE can we get a pity strong close?

1 · Reply

MrPeanutEsquire Jun. 18 at 7:32 PM

$PFE At this rate, were going to be red for the next three days...

0 · Reply

dark_gamma Jun. 18 at 7:17 PM

$PFE Whale Levels & Daily Premium Insights Last: $25.25 Critical Support Zones: $25.52 ($441.7M) | $25.66 ($706.5M) | $25.89 ($477.8M) Stay ahead of market movements with our daily analysis and updates. #PFE #Options #Trading #GEX #GammaExposure

0 · Reply

StocktwitsNews Jun. 18 at 7:16 PM

PFE Stock Drops 3% On Surprise CFO Exit Despite Reaffirmed 2026 Guidance $PFE $VTI $VOO https://stocktwits.com/news/equity/markets/pfe-stock-drops-on-surprise-cfo-exit-despite-reaffirmed-2026-guidance/cZKkgP9R77r

0 · Reply

SellasgpsCurativeBAT11 Jun. 18 at 6:56 PM

$ABBV $MRK $PFE $SLS Shorts Dr. Stergiou spelled it out for you “We are strategically transitioning from a clinical-stage biotech company into a late-stage organization on the cusp of commercialization.” ✌️🙏❤️‍🩹

0 · Reply

SteveTexans Jun. 18 at 6:56 PM

$DAWN $TGTX @Knight4Life I saw the same with $ARRY. BO. Everyday it kept going up. BO on Father’s Day weekend by $PFE.

0 · Reply

SellasgpsCurativeBAT11 Jun. 18 at 6:42 PM

$ABBV $MRK $PFE $SLS “The second half of 2026 is poised to be one of the most catalyst-rich periods in SELLAS history. We are strategically transitioning from a clinical-stage biotech company into a late-stage organization on the cusp of commercialization. "At SELLAS, we are no longer simply talking about what could happen. Increasingly, we are talking about what is happening." This progress belongs to our extraordinary team-the scientists, physicians, clinical teams, and employees who work relentlessly every day.” 🎤 ✌️🙏❤️‍🩹

0 · Reply

SellasgpsCurativeBAT11 Jun. 18 at 6:41 PM

$ABBV $MRK $PFE $SLS Close money green $9.00+ ✌️🙏❤️‍🩹

0 · Reply

McReethie Jun. 18 at 6:31 PM

$MRNA Undervalued or Overvalued? https://www.tradeapes.com/stocks/MRNA $ABUS $PFE

0 · Reply

Market Cap	148.41B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.50
Forward PE	8.71
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	119,546,570
Avg Vol	34,777,719
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	44%
Beta	0.34
Analysts	Sell
Price Target	$29.28